• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Tuesday

    1/3/23 12:54:58 PM ET
    $AAPL
    $AKTX
    $APGN
    $ARQQ
    Computer Manufacturing
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AAPL alert in real time by email

     

    On Tuesday, 31 stocks hit new 52-week lows.

    Things to Consider About Today's 52-Week Lows:

    • The largest company by market cap to hit a new 52-week low was Apple (NASDAQ:AAPL).
    • Tuesday Morning (NASDAQ:TUEM) was the smallest firm by market cap to set a new 52-week low.
    • Biora Therapeutics (NASDAQ:BIOR)'s stock dropped the most, trading down 2329.76% to reach a new 52-week low.
    • Tuesday Morning (NASDAQ:TUEM) shares were the most resilient of the group, as shares actually moved up 0.0% in response to hitting its 52-week low.

    The following stocks created new 52-week lows on Tuesday:

    • Apple (NASDAQ:AAPL) shares set a new 52-week low of $125.23. The stock traded down 3.12%.
    • Rivian Automotive (NASDAQ:RIVN) shares reached a new 52-week low of $17.08 on Tuesday morning, moving down 6.48%.
    • Telefonica Brasil (NYSE:VIV) stock achieved a new 52-week low on Tuesday morning, hitting $6.63 and moving down 6.78%.
    • Life Storage (NYSE:LSI) stock hit $96.62 on Tuesday morning, setting a new 52-week low for a change of down 1.73%.
    • Informatica (NYSE:INFA) shares were down 4.97% for the day, having made a 52-week low of $15.31.
    • Livent (NYSE:LTHM) stock hit a new 52-week low of $18.57. The stock was down 5.33% on the session.
    • National Storage (NYSE:NSA) shares hit a yearly low of $35.31. The stock was down 2.05% on the session.
    • Lithium Americas (NYSE:LAC) stock hit $17.81 on Tuesday morning, setting a new 52-week low for a change of down 4.54%.
    • Luminar Technologies (NASDAQ:LAZR) stock drifted down 3.43% on Tuesday morning to hit a new 52-week low of $4.70.
    • Kenon Hldgs (NYSE:KEN) stock hit a new 52-week low of $31.08. The stock was down 5.81% on the session.
    • Shenandoah (NASDAQ:SHEN) shares were up 2.33% for the day, having made a 52-week low of $15.62.
    • Biora Therapeutics (NASDAQ:BIOR) stock achieved a new 52-week low on Tuesday morning, hitting $3.08 and moving up 2329.76%.
    • NOVONIX (NASDAQ:NVX) stock achieved a new 52-week low on Tuesday morning, hitting $3.82 and moving down 6.83%.
    • Arqit Quantum (NASDAQ:ARQQ) shares made a new 52-week low of $3.11 on Tuesday. The stock was down 11.22% for the day.
    • PCB Bancorp (NASDAQ:PCB) stock dropped to a yearly low on Tuesday of $17.59. Shares traded down 0.51%.
    • Charge Enterprises (NASDAQ:CRGE) shares were down 3.23% for the day, having made a 52-week low of $1.17.
    • DLH Hldgs (NASDAQ:DLHC) shares hit a yearly low of $11.60. The stock was down 1.39% on the session.
    • Bakkt Hldgs (NYSE:BKKT) stock set a new 52-week low of $1.15 on Tuesday, moving down 2.52%.
    • Durect (NASDAQ:DRRX) shares set a new 52-week low of $3.17. The stock traded down 0.04%.
    • Akari Therapeutics (NASDAQ:AKTX) shares hit a yearly low of $0.38. The stock was up 8.47% on the session.
    • UpHealth (NYSE:UPH) shares set a new 52-week low of $1.59. The stock traded down 2.45%.
    • Biotricity (NASDAQ:BTCY) stock hit a yearly low of $0.43. The stock was down 3.37% for the day.
    • Apexigen (NASDAQ:APGN) shares hit a yearly low of $0.61. The stock was down 4.69% on the session.
    • Paltalk (NASDAQ:PALT) shares set a new 52-week low of $1.28. The stock traded up 2.27%.
    • Ontrak (NASDAQ:OTRK) stock hit a yearly low of $0.34. The stock was up 0.11% for the day.
    • Liminal Biosciences (NASDAQ:LMNL) stock hit $0.31 on Tuesday morning, setting a new 52-week low for a change of down 4.62%.
    • Genius Gr (AMEX:GNS) shares set a new 52-week low of $0.30. The stock traded up 2.85%.
    • Ayala Pharmaceuticals (NASDAQ:AYLA) shares hit a yearly low of $0.36. The stock was up 2.15% on the session.
    • BiondVax Pharmaceuticals (NASDAQ:BVXV) shares were down 2.03% for the day, having made a 52-week low of $2.80.
    • China Pharma Holding (AMEX:CPHI) shares set a new yearly low of $0.08 this morning. The stock was down 6.47% on the session.
    • Tuesday Morning (NASDAQ:TUEM) shares reached a new 52-week low of $0.35 on Tuesday morning, moving 0.0% (flat).

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $AAPL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAPL
    $AKTX
    $APGN
    $ARQQ

    CompanyDatePrice TargetRatingAnalyst
    Apple Inc.
    $AAPL
    1/30/2026$315.00 → $325.00Overweight
    Analyst
    Apple Inc.
    $AAPL
    1/30/2026$230.00 → $239.00Underweight
    Barclays
    Apple Inc.
    $AAPL
    1/30/2026$250.00 → $267.00Neutral
    Rosenblatt
    Apple Inc.
    $AAPL
    1/30/2026$300.00 → $315.00Buy
    Monness Crespi & Hardt
    Apple Inc.
    $AAPL
    1/30/2026$300.00Hold → Buy
    Maxim Group
    Apple Inc.
    $AAPL
    1/26/2026$305.00 → $315.00Overweight
    Analyst
    National Storage Affiliates Trust
    $NSA
    1/26/2026Underperform → Peer Perform
    Wolfe Research
    Rivian Automotive Inc.
    $RIVN
    1/14/2026$15.00Neutral → Sell
    UBS
    More analyst ratings

    $AAPL
    $AKTX
    $APGN
    $ARQQ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays reiterated coverage on Apple with a new price target

    Barclays reiterated coverage of Apple with a rating of Underweight and set a new price target of $239.00 from $230.00 previously

    1/30/26 8:00:23 AM ET
    $AAPL
    Computer Manufacturing
    Technology

    Analyst reiterated coverage on Apple with a new price target

    Analyst reiterated coverage of Apple with a rating of Overweight and set a new price target of $325.00 from $315.00 previously

    1/30/26 8:00:23 AM ET
    $AAPL
    Computer Manufacturing
    Technology

    Rosenblatt reiterated coverage on Apple with a new price target

    Rosenblatt reiterated coverage of Apple with a rating of Neutral and set a new price target of $267.00 from $250.00 previously

    1/30/26 8:00:23 AM ET
    $AAPL
    Computer Manufacturing
    Technology

    $AAPL
    $AKTX
    $APGN
    $ARQQ
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    September 17, 2024 - FDA Roundup: September 17, 2024

    For Immediate Release: September 17, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a draft guidance, “Integrating Randomized Controlled Trials for Drug and Biological Products into Routine Clinical Practice,” which, when finalized, will support the conduct of randomized controlled trials with streamlined protocols a

    9/17/24 2:34:22 PM ET
    $AAPL
    Computer Manufacturing
    Technology

    September 12, 2024 - FDA Authorizes First Over-the-Counter Hearing Aid Software

    For Immediate Release: September 12, 2024 Today, the U.S. Food and Drug Administration authorized the first over-the-counter (OTC) hearing aid software device, Hearing Aid Feature, intended to be used with compatible versions of the Apple AirPods Pro headphones. Once installed and customized to the user’s hearing needs, the Hearing Aid Feature enables compatible versions of the AirPods Pro to serve as an OTC hea

    9/12/24 10:58:17 AM ET
    $AAPL
    Computer Manufacturing
    Technology

    FDA Approval for POSIMIR

    Submission status for DURECT CORP's drug POSIMIR (ORIG-1) with active ingredient BUPIVACAINE has changed to 'Approval' on 02/01/2021. Application Category: NDA, Application Number: 204803, Application Classification: Type 3 - New Dosage Form

    2/2/21 7:24:30 AM ET
    $DRRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAPL
    $AKTX
    $APGN
    $ARQQ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Baes Nicholas decreased direct ownership by 5% to 101,023 units (SEC Form 5)

    5 - Bakkt, Inc. (0001820302) (Issuer)

    2/6/26 7:02:42 PM ET
    $BKKT
    Finance: Consumer Services
    Finance

    VP Chief HRO Tormey Heather K was granted 5,606 shares and covered exercise/tax liability with 1,983 shares, increasing direct ownership by 23% to 19,322 units (SEC Form 4)

    4 - SHENANDOAH TELECOMMUNICATIONS CO/VA/ (0000354963) (Issuer)

    2/5/26 9:32:35 PM ET
    $SHEN
    Telecommunications Equipment
    Telecommunications

    SVP Sales & Marketing Leslie Dara was granted 7,259 shares and covered exercise/tax liability with 2,528 shares, increasing direct ownership by 83% to 10,404 units (SEC Form 4)

    4 - SHENANDOAH TELECOMMUNICATIONS CO/VA/ (0000354963) (Issuer)

    2/5/26 9:27:01 PM ET
    $SHEN
    Telecommunications Equipment
    Telecommunications

    $AAPL
    $AKTX
    $APGN
    $ARQQ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Shenandoah Telecommunications Company to Hold its Fourth Quarter and Full Year 2025 Earnings Call at 8:30 a.m. on Thursday, February 26, 2026

    EDINBURG, Va., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Shenandoah Telecommunications Company (Shentel) (NASDAQ:SHEN) will release its fourth quarter and full year 2025 financial results before the market opens on Thursday, February 26, 2026, and will host a conference call and simultaneous webcast on the same day at 8:30 a.m. Eastern Time to discuss Shentel's financial results and business highlights. Date: February 26, 2026Time: 8:30 AM ET Listen via Internet: https://investor.shentel.com/ For Analysts, please register to dial-in at this link. A replay of the call will be available for a limited time on the Investor Relations page of the Company's website. About Shenandoah Telecommunicatio

    2/5/26 4:15:00 PM ET
    $SHEN
    Telecommunications Equipment
    Telecommunications

    Biotricity to Announce Continued Growth in Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11th

    Company continues to drive Revenue Growth, Margin Strength, Operational Efficiency, and continued positive EBITDA REDWOOD CITY, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), an innovative Technology-as-a-Service (TaaS) company committed to redefining the landscape of the healthcare industry with state-of-the-art remote monitoring and diagnostic solutions, announced that it will host its Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11th, at 4:30 PM Eastern Time. The Company announces continued progress in its financial performance, including achieving a positive EBITDA and continued growth. Biotricity's Founder and CEO, Dr. Waqa

    2/5/26 4:15:00 PM ET
    $BTCY
    Medical/Dental Instruments
    Health Care

    Akari Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial

    – Live video webcast on Tuesday, February 10th at 1:00 PM EST TAMPA, Fla. and LONDON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company pioneering next-generation antibody drug conjugates (ADCs) powered by novel RNA-splicing payloads, today announced that it will participate in the Corporate Connect Webinar Series hosted by Webull Financial being held virtually February 10-11, 2026. As part of the presentation, Abizer Gaslightwala, Director, President and CEO of Akari Therapeutics, will provide a corporate overview highlighting the Company's next-generation antibody drug conjugate platform and proprietary PH1 spliceosome-modulatin

    2/5/26 9:15:00 AM ET
    $AKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAPL
    $AKTX
    $APGN
    $ARQQ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Mink Brook Asset Management Llc bought $27,648 worth of shares (5,027 units at $5.50) (SEC Form 4)

    4 - DLH Holdings Corp. (0000785557) (Issuer)

    1/8/26 4:28:20 PM ET
    $DLHC
    Professional Services
    Consumer Discretionary

    Large owner Mink Brook Asset Management Llc bought $243,573 worth of shares (44,286 units at $5.50) (SEC Form 4)

    4 - DLH Holdings Corp. (0000785557) (Issuer)

    12/18/25 4:40:16 PM ET
    $DLHC
    Professional Services
    Consumer Discretionary

    Large owner Mink Brook Asset Management Llc bought $5,082 worth of shares (924 units at $5.50) (SEC Form 4)

    4 - DLH Holdings Corp. (0000785557) (Issuer)

    12/12/25 4:43:11 PM ET
    $DLHC
    Professional Services
    Consumer Discretionary

    $AAPL
    $AKTX
    $APGN
    $ARQQ
    SEC Filings

    View All

    SEC Form 6-K filed by Genius Group Limited

    6-K - Genius Group Ltd (0001847806) (Filer)

    2/6/26 9:00:18 AM ET
    $GNS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    SEC Form PREM14A filed by Bakkt Inc.

    PREM14A - Bakkt, Inc. (0001820302) (Filer)

    2/4/26 9:59:10 AM ET
    $BKKT
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SCHEDULE 13D/A filed by Lithium Americas Corp.

    SCHEDULE 13D/A - LITHIUM AMERICAS CORP. (0001966983) (Subject)

    2/3/26 4:05:02 PM ET
    $LAC
    Metal Mining
    Basic Materials

    $AAPL
    $AKTX
    $APGN
    $ARQQ
    Leadership Updates

    Live Leadership Updates

    View All

    Rivian Hires Greg Revelle as Chief Customer Officer

    Revelle Brings Deep Experience in eCommerce and Marketing to American Automaker Rivian (NASDAQ:RIVN) today announced the appointment of Greg Revelle to Chief Customer Officer (CCO) of Rivian. Revelle joins Rivian from Revatek, a startup he founded dedicated to enhancing the off-grid outdoor experience through innovative energy storage. He has also held leadership roles at Kohl's, Best Buy, AutoNation and Expedia, in addition to being a current board member at Cars.com. Beginning today, Revelle will oversee the entirety of the customer journey at Rivian, leading its go-to-market strategy, including sales, marketing and operations. "We are excited that Greg is bringing his deep experience

    1/12/26 9:27:00 AM ET
    $RIVN
    Auto Manufacturing
    Industrials

    Bakkt Agrees to Acquire Distributed Technologies Research Ltd.

    - Acquisition advances Bakkt's global stablecoin settlement and programmable payments strategy- Company to operate as "Bakkt, Inc." effective January 22, 2026- Investor Day scheduled for March 17, 2026 at the New York Stock Exchange NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Bakkt Holdings, Inc. ("Bakkt" or the "Company") (NYSE:BKKT) today announced that it has agreed to acquire Distributed Technologies Research Ltd. ("DTR"), a global stablecoin payment infrastructure provider. Pursuant to the definitive agreement, and as consideration for DTR, Bakkt will issue shares of its Class A common stock representing 31.5% of the "Bakkt Share Number," as defined in the previously announced Coope

    1/12/26 8:00:00 AM ET
    $BKKT
    Finance: Consumer Services
    Finance

    Genius Group Engages DLA Piper as Advisor on Australian Securities Exchange (ASX) Dual Listing.

    SINGAPORE, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE:GNS) ("Genius Group" or the "Company"), a leading AI-powered, Bitcoin-first education group, today announced that it has appointed DLA Piper as advisor on the Company's application for a dual listing on Australian Securities Exchange (ASX). Following the Company's Board of Directors approval on August 8, 2025 to pursue a dual listing on an Asia Pacific exchange to enhance shareholder value and accessibility, the Company has been investigating potential stock exchanges, resulting in a shortlist of three exchanges in Australia (ASX), South Korea (KRX) and Hong Kong (HKEX). From the shortlist, the Company has selected t

    12/18/25 8:00:00 AM ET
    $GNS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $AAPL
    $AKTX
    $APGN
    $ARQQ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Arqit Quantum Inc.

    SC 13D/A - Arqit Quantum Inc. (0001859690) (Subject)

    12/13/24 8:03:28 PM ET
    $ARQQ
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Arqit Quantum Inc.

    SC 13D/A - Arqit Quantum Inc. (0001859690) (Subject)

    12/10/24 8:05:26 PM ET
    $ARQQ
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Akari Therapeutics plc

    SC 13D/A - Akari Therapeutics Plc (0001541157) (Subject)

    12/6/24 4:00:28 PM ET
    $AKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAPL
    $AKTX
    $APGN
    $ARQQ
    Financials

    Live finance-specific insights

    View All

    Shenandoah Telecommunications Company to Hold its Fourth Quarter and Full Year 2025 Earnings Call at 8:30 a.m. on Thursday, February 26, 2026

    EDINBURG, Va., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Shenandoah Telecommunications Company (Shentel) (NASDAQ:SHEN) will release its fourth quarter and full year 2025 financial results before the market opens on Thursday, February 26, 2026, and will host a conference call and simultaneous webcast on the same day at 8:30 a.m. Eastern Time to discuss Shentel's financial results and business highlights. Date: February 26, 2026Time: 8:30 AM ET Listen via Internet: https://investor.shentel.com/ For Analysts, please register to dial-in at this link. A replay of the call will be available for a limited time on the Investor Relations page of the Company's website. About Shenandoah Telecommunicatio

    2/5/26 4:15:00 PM ET
    $SHEN
    Telecommunications Equipment
    Telecommunications

    Biotricity to Announce Continued Growth in Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11th

    Company continues to drive Revenue Growth, Margin Strength, Operational Efficiency, and continued positive EBITDA REDWOOD CITY, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), an innovative Technology-as-a-Service (TaaS) company committed to redefining the landscape of the healthcare industry with state-of-the-art remote monitoring and diagnostic solutions, announced that it will host its Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11th, at 4:30 PM Eastern Time. The Company announces continued progress in its financial performance, including achieving a positive EBITDA and continued growth. Biotricity's Founder and CEO, Dr. Waqa

    2/5/26 4:15:00 PM ET
    $BTCY
    Medical/Dental Instruments
    Health Care

    DLH to Announce Fiscal 2026 First Quarter Financial Results

    ATLANTA, Feb. 02, 2026 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ:DLHC) ("DLH" or the "Company"), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies, will release financial results for the fiscal first quarter ended December 31, 2025 on February 9, 2026 after the market closes. DLH will then host a conference call for the investment community at 10:00 a.m. Eastern Time the following day, February 10, 2026, during which members of senior management will make a brief presentation focused on the financial results and operating trends. A question-and-answer session will fol

    2/2/26 8:00:00 AM ET
    $DLHC
    Professional Services
    Consumer Discretionary